Social News
Author: Zhu Haiqi
2021-01-24 13:43
Last update date: 2021-01-24 13:45
More than 40,000 people in Norway have been vaccinated with the German BioNTech/Pfizer vaccine, and 33 elderly people have passed away.
The World Health Organization's global advisory committee responsible for vaccine safety issued a statement on the 22nd of this month stating that the cause of death and mortality of the deceased were in line with expectations, and there was no data confirming that vaccination caused them to die.
The BioNTech vaccine is purchased in Hong Kong. Experts from the Vaccine Advisory Committee urged the public not to panic. Hong Kong has a dedicated person to review the side effects of the vaccine.
The WHO's global advisory committee responsible for vaccine safety issued a statement on the 22nd of this month that the mortality and cause of death in the frail elderly cases were in line with expectations. The existing data failed to confirm that vaccination caused their deaths. After weighing the pros and cons, it believed that the Vaccination is still advantageous.
33 elders in Norway died after being vaccinated with BioNTech. The local government once said that the vaccine caused them to die, but on the 18th of this month, they changed their narrative and said that they were not related.
Xu Shuchang, member of the Committee of Government Vaccine Advisory Experts and Chair Professor of Respiratory Department of CUHK, urged the public not to panic about the Norwegian incident. The youngest death in Norway is a 75-year-old elder. All the dead have long-term illnesses. When vaccinated in Hong Kong, there will be special personnel to monitor vaccine Will also pay attention to overseas data.
Xu Shuchang urged the public not to panic about the Norwegian incident. When the vaccine is received in Hong Kong, a dedicated person will monitor the side effects of the vaccine.
(Data Picture / Photo by Yu Junliang)
BioNTech vaccine arrives in Hong Kong in 6 installments
He quoted the official responsible for the procurement of vaccines from the Food and Health Bureau as saying that the BioNTech vaccine will arrive in Hong Kong 6 times, with 1 million doses for the first 3 times and 1.5 million doses for the last 3 times. I believe the news is accurate. The first batch of vaccines will be next month. Arrive at the end of (February).
Another Mainland Kexing vaccine, which has a procurement agreement with Hong Kong, still has no third phase clinical report.
Xu Shuchang pointed out that both the WHO and the Hong Kong Department of Health Co. Ltd. will submit data on a specified date, and Coxing has a procurement agreement with Hong Kong. Therefore, it is now necessary to give the opportunity to Coxing to submit the data. The department will hold the data after collecting the data. The scientific committee followed up.
As for whether Hong Kong needs to purchase a Sinopharm vaccine that uses the same inactivated technology as Kexing, Xu Shuchang said that in principle, Hong Kong will have one vaccine for every technology.
New Coronary Pneumonia｜WHO: There is no evidence that Pfizer vaccine causes the death of frail elderly
Anti-epidemic for one year | The Hospital Authority sets up seven vaccine centers, but it is difficult for hospitalized patients to receive injections
Anti-epidemic for one year.
Interview｜Zeng Haohui retired for 8 years and came out of the mountain to promote self-deprecating new crown vaccine
Interview｜BioNTech's new crown vaccine arrives in Hong Kong first, Haohui Zeng will be vaccinated pending clinical report purchase Kexing
Interview｜Zeng Haohui is worried about swine flu piracy, citizens are not confident about getting a new crown vaccine, experts must explain quickly
01News
New crown pneumonia new crown vaccine
